The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index; 2 of the 9 sources its claims cite were checked for support.
A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India
Open accessAbstract
BACKGROUND: Donor vigilance is the monitoring of donor adverse events (DAEs) to improve donor safety and the quality of the blood donation process. This study aimed to grade and assess DAEs using a new severity grading tool (SGT) by the Hemovigilance Programme of India and to identify factors influencing it. MATERIALS AND METHODS: A single-center prospective observational study was conducted over 14 months among whole blood and apheresis donors with DAEs. Data was recorded in the Adverse Blood Donor Reaction Reporting Form-2 and supplemented with Blood Centre records. Data were compiled in Microsoft Excel and analyzed using DATAtab 2023. RESULTS: Out of 11,171 registered blood donors, 7188 were eligible for donation. The overall incidence of DAEs was 288 (4.0%), out of them 0.3% occurred in predonation, 20.5% during donation, and 79.2% in postdonation. Among the DAEs, 95.8% were Grade 1, and 4.2% were Grade 2. DAEs were significantly higher in females, first-time, and apheresis donors, with increased incidence during noon time, summer season, and outdoor camps. Generalized vasovagal reactions were the most common. CONCLUSION: Four out of 100 donors were experiencing DAE, and the majority was of Grade 1 severity. Strategies may be adopted to mitigate DAEs among those who are predisposed to DAEs. In addition, unreported delayed DAEs are of further concern for the blood center. Our study found that SGT effectively improves the objective severity grading of DAEs. Terminologies like outside medical care are less relevant in India, where most blood donors with DAEs are managed by the medical team at the blood centre.
Overview
CoChat Summary
TL;DR
This single-center prospective study graded donor adverse events (DAEs) using the Hemovigilance Programme of India severity grading tool and found an overall DAE incidence of 4.0% among 7,188 eligible donors. Most DAEs were Grade 1 and occurred postdonation, with higher rates in females, first-time donors, and apheresis donors.
Key findings
- Among 11,171 registered donors, 7,188 were eligible; 288 DAEs occurred (4.0%). By timing, 0.3% (n = 1) were predonation, 20.5% (n = 59) during donation, and 79.2% (n = 228) postdonation.
- Severity grading showed 95.8% (n = 276) Grade 1 and 4.2% (n = 12) Grade 2; imputability was “Definite” for 99.3% (n = 286) and “Probable” for 0.7% (n = 2).
- DAEs were significantly higher in females (7.2%) than males (3.4%), first-time donors (6.8%) than repeat donors (2.5%, P < 0.001), and outdoor camps (5.0%) than the Blood Centre (2.5%).
- Generalized vasovagal reactions were most common; VVR incidence among platelet apheresis donors was 18.2%, and vasovagal DAEs were higher in summer months February–April (P = 0.0053).
Methods
- Single-center prospective observational study conducted over 14 months (June 2022–July 31, 2023) among whole blood and apheresis donors at a tertiary care hospital-based blood center.
- Data were recorded in the Adverse Blood Donor Reaction Reporting Form-2 and supplemented with Blood Centre records; donors were followed up for 2 weeks to monitor complications.
- Analysis used DATAtab 2023, with chi-square tests for nonparametric variables and t-tests for parametric variables in univariate analysis.
Limitations
- The paper states that plateletpheresis collections at the center were limited and that some donors may not have reported delayed DAEs due to confusion or misunderstanding despite thorough explanation.
- The text makes evident that delayed DAEs may be undercounted because reporting depended on donor callback/follow-up, and the authors note unreported delayed DAEs remain a concern for blood centers.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
2 Valid · 0 Not valid · 7 Not checked · 45 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This can be attributed to the fact that preferably we used 350 mL bags for blood donors <55 kg and first-time donors who are higher risk for DAEs.[11]”
§ A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India > Discussion
What the sources say
- Partly supportedcites [11] Agnihotri N Marwaha N Sharma RR Analysis of adverse events and predisposing factors in voluntary and replacement whole blood donors: A study from north India Asian J Transfus Sci 2012 6 155 60 22988381 PMC3439755 sourceExperimental — accuracy not yet measured
The Abstract and Discussion (Risk factors for AEs; page not available) associate adverse events with first-time platelet donation and lower BMI, and the Discussion also reports higher risk with low weight. The paper does not assess 350 mL bags, a <55 kg cutoff, or whether preferential bag use explains a higher incidence of donor adverse events. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A study involving 50 blood centers in India found that in 43.6% of cases, different centers failed to agree on the diagnosis or severity grade.[25]”
§ A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India > Discussion
What the sources say
- Partly supportedcites [25] Bisht A Arora S Patidar G Marwaha N Knowledge assessment of a donor adverse reaction severity grading tool by the National Blood Donor Vigilance Programme of India Vox Sang 2023 118 721 9 37533234 sourceExperimental — accuracy not yet measured
The Results section says 50 Indian blood centres were included, and the Analysis of disagreement section identifies incorrect diagnosis and incorrect severity grading as sources of disagreement. But Overall cases reports 66.4% agreement between centres and the expert group—33.6% disagreement, not 43.6%—and does not describe agreement between different centres. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“95.8% were Grade 1”
- Also stated in: § Severity grading of donor adverse events · plain
“Grade 1 for 95.8% (n = 276) of the DAEs”
§ A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India > Abstract > RESULTS:
plainn = 276- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Severity grading of donor adverse events · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“20.5% during donation”
- Also stated in: § Results · plain
“20.5% (n = 59) during donation”
§ A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India > Abstract > RESULTS:
plainn = 59- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Generalized (vasovagal) type of DAEs was the most common among this study and contributed 61.5%.”
§ A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
32 more claims
Create a free account to see all 54 claims and every source verdict.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 10
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“DAEs with generalized symptoms (91.7%, n = 177) were more common than localized (33.3%, n = 96)”
§ A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India > Results > Generalized versus localized donor adverse events
Reported 91.7 · recomputed 61.458333
Citations
Cites
The effect of whole-blood donor adverse events on blood donor return rates
Newman, B. H., Newman, D. T., Ahmad, R., & Roth, A. J. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00905.x · Cited by 190 · cited 1×
“[4,7] The Donor vigilance is still in the development phase in India; consistent reporting and the minimum inter-and intra-observer variation will help in improving the donor care and safety.”
The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006
Eder, A. F., Dy, B. A., Kennedy, J. M., Notari IV, E. P., Strupp, A., Wissel, M. E., Reddy, R., Gibble, J., Haimowitz, M. D., Newman, B. H., et al. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01811.x · Cited by 149 · cited 2×
“[4,7] The Donor vigilance is still in the development phase in India; consistent reporting and the minimum inter-and intra-observer variation will help in improving the donor care and safety.”
InfluentialMild reactions to blood donation predict a decreased likelihood of donor return
France, C. R., France, J. L., Roussos, M., & Ditto, B. (2003) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2003.08.014 · Cited by 124 · cited 2×
“[6] Adverse events negatively affect donor health, satisfaction, and blood donor return rate.”
Crocco, A., & D'Elia, D. (2007) · PubMed · doi:10.2450/2007.0005-07 · Cited by 84
Marwaha, N., Agnihotri, N., & Sharma, R. (2012) · Asian Journal of Transfusion Science · doi:10.4103/0973-6247.98922 · Cited by 62 · cited 2×
“[11] The average climate in Kerala includes a rainy season from May to October and comparatively cooler weather from November to January.”
InfluentialApplied tension and blood donation symptoms: The importance of anxiety reduction.
Holly, C. D., Balegh, S., & Ditto, B. (2011) · Health Psychology · doi:10.1037/a0022998 · Cited by 45
Adverse Reactions in Allogeneic Blood Donors: A Tertiary Care Experience from a Developing Country
(2016) · Oman Medical Journal · doi:10.5001/omj.2016.24 · Cited by 22 · cited 1×
“13-15] The incidence of DAEs was significantly higher among the blood donations at outdoor donation camps (5.0”
InfluentialDogra, A., Sidhu, M., Dogra, M., & Raina, T. R. (2015) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-014-0396-y · Cited by 21 · cited 1×
“[Figure 3].”
National blood donor vigilance programme of India
Bisht, A., Marwaha, N., Arora, S., Patidar, G. K., & Chhabra, R. (2021) · Asian Journal of Transfusion Science · doi:10.4103/ajts.ajts_195_20 · Cited by 20 · cited 1×
“[16,17] The incidence of DAEs among first-time blood donors (6.8”
InfluentialAgarwal, R., Periyavan, S., Dhanya, R., Parmar, L., Sedai, A., Ankita, K., Vaish, A., Sharma, R., & Gowda, P. (2015) · Asian Journal of Transfusion Science · doi:10.4103/0973-6247.165840 · Cited by 19
Research works printed but not linked: 2
- Das, 2016, Hemovigilance: An institutional study, Int J Sci Res, 5, 203
- Rai, 2018, Adverse reaction in whole blood donors at a tertiary care Centre, Gwalior, IOSR J Dent Med Sci, 17, 31
Metadata
- Authors
- Patel, P., Rajendran, V., Nair, A. R., & Gupta, D.
- Affiliations
- Sree Chitra Thirunal Institute for Medical Sciences and Technology (IN)
- Corresponding author
- Gupta, Debasish
- Venue
- Asian Journal of Transfusion Science
- Published
- 2025-09-05
- Volume
- 20
- Issue
- 1
- Pages
- 50-57
- ISSN
- 0973-6247 (ISSN-L)
- 1998-3565
- PMC
- PMC13290225
- OpenAlex
- W7082630150
- Semantic Scholar
- 3012e09204160c64ad6d283998770f139de9ebf8
- Cited by
- 0
- References
- 18
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Asian Journal of Transfusion Science (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- PubMed Central (submittedVersion, cc-by-nc-sa)
- Topics
- Health Sciences › Medicine › Hematology › Blood donation and transfusion practices
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- hemovigilance, blood donor safety, apheresis donors, whole blood donors, risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India. https://app.cochat.ai/papers/10.4103/ajts.ajts_154_24
- The paper
- Patel, P., Rajendran, V., Nair, A. R., & Gupta, D. (2026). A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India. Asian Journal of Transfusion Science. https://doi.org/10.4103/ajts.ajts_154_24
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.